Literature DB >> 23724151

Continuous spinal anesthesia with sufentanil in labor analgesia can induce maternal febrile responses in puerperas.

Fubo Tian1, Kai Wang, Jianying Hu, Yi Xie, Shen Sun, Zui Zou, Shaoqiang Huang.   

Abstract

UNLABELLED: Several studies documented persistent hypothermia in parturients after spinal anesthesia, while others reported that labor analgesia was related to a high incidence of fever. Continuous spinal labor anesthesia with sufentanil (CSLAS) is a new effective technique in labor analgesia but whether it affects maternal temperature has not been clarified. The aim of our study was to explore the relationship between CSLAS and maternal intrapartum temperature during vaginal delivery.
METHODS: 75 healthy term nulliparas of spontaneous labor were randomized to receive CSLAS during delivery in sufentanil group (n=37) or non-pharmacological methods of pain relief in control group (n=38). The maternal tympanic temperature was recorded at each time points we required during labor. IL-6, IL-8 and TNF-α were sampled at baseline (before analgesia) and 5 minutes after delivery. The data on visual analog scale (VAS) in all puerperas, first and second stage durations of labor, vaginal examination, oxytocin augmentation, maternal and neonatal antibiotic therapy, maternal and neonatal infection, need for cesarean section, need for instrumental delivery and Apgar scores were all collected from the patients' medical records. RESULT: Baseline characteristics of parturients in the 2 groups were not significant differences. After intrathecal injection of sufentanil, the sensation of pain was attenuated by a wide margin in the sufentanil group compared with the control group. Nine parturients in the sufentanil group (24.32%) and two in the control group (5.26%) had a tympanic temperature above 38°C during the labor (p=0.024). In each group, there was a tendency that maternal temperature elevated gradually with time elapsing and reached the peak value 5 hours after baseline. The changes had significant difference from 3 hours to 7 hours after analgesia compared with baseline. Maternal serum IL-6 and IL-8 levels were increased during the labor, while TNF-α did not vary at any time point in each group. 1 min and 5 min Apgar scores were not significant difference in the two groups and no neonate developed temperature above 38°C in the first 24 hours and with antibiotic therapy.
CONCLUSION: The technique of continuous sufentanil spinal labor anesthesia is a safe and effective method in labor analgesia; however, it is associated with an increased incidence of maternal fever.

Entities:  

Keywords:  Analgesia; CSLAS; continuous spinal labor anesthesia; fever; labor pain; maternal temperature; sufentanil

Year:  2013        PMID: 23724151      PMCID: PMC3663999     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

Review 1.  Persistent hypothermia after intrathecal morphine: case report and literature review.

Authors:  Kenneth F Ryan; James W Price; C Brian Warriner; Peter T Choi
Journal:  Can J Anaesth       Date:  2011-12-10       Impact factor: 5.063

Review 2.  Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system.

Authors:  Andrej A Romanovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-09-28       Impact factor: 3.619

3.  [Severe hypothermia associated with cesarean section under spinal anesthesia].

Authors:  P Peillon; M Dounas; J J Lebonhomme; Y Guittard
Journal:  Ann Fr Anesth Reanim       Date:  2002-04

Review 4.  [Epidural analgesia and fever during labor].

Authors:  L Thierrin; F-J Mercier
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2005-09

5.  Elevated maternal and fetal serum interleukin-6 levels are associated with epidural fever.

Authors:  Laura Goetzl; Tracy Evans; Jose Rivers; Maya S Suresh; Ellice Lieberman
Journal:  Am J Obstet Gynecol       Date:  2002-10       Impact factor: 8.661

6.  The influence of anaesthetic techniques and type of delivery on peripartum serum interleukin-6 concentrations.

Authors:  R F De Jongh; E P Bosmans; M J Puylaert; W U Ombelet; H J Vandeput; R A Berghmans
Journal:  Acta Anaesthesiol Scand       Date:  1997-08       Impact factor: 2.105

7.  Morphine and d-amphetamine nullify each others' hypothermic effects in mice.

Authors:  Alexis Baker; Theo Meert
Journal:  Pharmacol Toxicol       Date:  2003-02

8.  Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.

Authors:  Peter Salmi; Johanna Kela; Ulf Arvidsson; Claes Wahlestedt
Journal:  Eur J Pharmacol       Date:  2003-01-01       Impact factor: 4.432

Review 9.  Epidural versus non-epidural or no analgesia in labour.

Authors:  Millicent Anim-Somuah; Rebecca Md Smyth; Leanne Jones
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

10.  Maternal and cord serum cytokine changes with continuous and intermittent labor epidural analgesia: a randomized study.

Authors:  Venkat R Mantha; Manuel C Vallejo; Vimala Ramesh; Bobby L Jones; Sivam Ramanathan
Journal:  ScientificWorldJournal       Date:  2012-05-01
View more
  3 in total

1.  ER stress related factor ATF6 and caspase-12 trigger apoptosis in neonatal hypoxic-ischemic encephalopathy.

Authors:  Luran Liu; Chang Liu; Yuting Lu; Lina Liu; Yan Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 2.  Interventions for the prevention or treatment of epidural-related maternal fever: a systematic review and meta-analysis.

Authors:  Anna Cartledge; Daniel Hind; Mike Bradburn; Marrissa Martyn-St James; Sophie Davenport; Wei Shao Tung; Hwu Yung; Jeyinn Wong; Matthew Wilson
Journal:  Br J Anaesth       Date:  2022-08-05       Impact factor: 11.719

3.  Comparison Between the Use of Ropivacaine Alone and Ropivacaine With Sufentanil in Epidural Labor Analgesia.

Authors:  Xian Wang; Shiqin Xu; Xiang Qin; Xiaohong Li; Shan-Wu Feng; Yusheng Liu; Wei Wang; Xirong Guo; Rong Shen; Xiaofeng Shen; Fuzhou Wang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.